Ide Smets retweetet

@drruthdobson (UK) and @SmetsIde (The Netherlands) explore the practicalities of therapeutic sequencing options in MS.
Watch now: ow.ly/FTEX50OMQV5
#MedTwitter #Neurology #NeuroImmunology #MS #MultipleSclerosis #MedEd

English
Ide Smets
98 posts

@SmetsIde
Neurologist@ErasMS_Rdam. Past ECTRIMS Clinical Fellow at Barts-MS London. Mainly talking 🧠-sense!



























Great debate about #AHSCT for #MS first lineat #CONy2022. “Hematopoietic stem cell therapies (HSCT) should be offered as a first line DMT in selected MS patients: NO?” I am glad to report that I lost the debate. #neurologist are ready to embrace #AHSCT. @Boaz_Spermon @AANMember
